双序贯体外除颤治疗难治性心室颤动的院外心脏骤停:系统评价与Meta分析
该系统评价检索了Ovid Medline、EMBASE、CINAHL、SCOPUS、Cochrane图书馆(建库至2018年1月29日)及Google学术灰色文献,最终纳入两项回顾性研究,无随机对照试验。汇总人群499例,其中19%(n=95)接受双序贯体外除颤,81%(n=404)接受标准复苏方案。双序贯体外除颤对出院生存(OR 0.69,95%CI:0.30,1.60)、事件生存(OR 0.98,95%CI:0.59,1.62)或自主循环恢复(OR 0.86,95%CI:0.49,1.48)均无显著影响。作者认为双序贯体外除颤的有效性仍不明确。
要点
- 汇总499例难治性心室颤动患者,双序贯体外除颤组95例与标准复苏组404例相比,出院生存OR 0.69(95%CI:0.30,1.60),无显著差异。
- 双序贯体外除颤对事件生存(OR 0.98,95%CI:0.59,1.62)和自主循环恢复(OR 0.86,95%CI:0.49,1.48)均无显著影响。
- 仅纳入两项回顾性研究,无随机对照试验,双序贯体外除颤确认由急救人员自我报告。
- 两项研究均未校正混杂因素或组间基线特征,难治性心室颤动定义和双序贯体外除颤方案在各研究间不同。
- 目击心脏骤停占58.7%(n=293),旁观者心肺复苏启动占53.3%(n=266)。
适用人群与场景
- 院外难治性心室颤动心脏骤停患者,纳入两项回顾性研究共499例,其中19%(n=95)接受双序贯体外除颤,81%(n=404)接受标准复苏方案。
研究设计与关键结果
- 系统评价与Meta分析,检索Ovid Medline、EMBASE、CINAHL、SCOPUS、Cochrane图书馆(建库至2018年1月29日)及Google学术灰色文献,初检5351条唯一记录,最终纳入两项回顾性研究,无随机对照试验。
- 汇总人群499例,双序贯体外除颤组95例(19%)与标准复苏组404例(81%)比较,出院生存OR 0.69(95%CI:0.30,1.60),无显著差异。
- 事件生存OR 0.98(95%CI:0.59,1.62),无显著差异。
- 自主循环恢复OR 0.86(95%CI:0.49,1.48),无显著差异。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入两项回顾性研究,无随机对照试验;采用Newcastle-Ottawa量表评估研究质量,随机效应模型(DerSimonian & Laird法)计算汇总OR及95%CI。
- 局限:仅两项回顾性研究;无随机对照试验;双序贯体外除颤确认由急救人员自我报告;两项研究均未校正混杂因素或组间基线特征;难治性心室颤动定义和双序贯体外除颤方案在各研究间不同;作者结论认为双序贯体外除颤有效性仍不明确,需进一步精心设计的前瞻性研究确定其在难治性心室颤动治疗中的作用。
对床旁实践的改变
- 作者认为双序贯体外除颤的有效性仍不明确,需进一步精心设计的前瞻性研究确定其在难治性心室颤动治疗中的作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Double sequential external defibrillation (DSED) is a novel intervention which has shown potential in the management of refractory ventricular fibrillation (VF). This review aims to identify the literature surrounding the use of DSED in out-of-hospital refractory VF and assess whether this intervention improves survival outcomes.
METHODS: The databases Ovid Medline, EMBASE, CINAHL, SCOPUS and the Cochrane Library were searched from their commencement to January 29th 2018. Google (scholar) was also searched for grey literature. We combined MeSH terms and text words for DSED in refractory VF and included studies that used an interventional or observational design. Study quality was assessed using the Newcastle-Ottawa Scale. A random effects model using the DerSimonian & Laird method was used to calculate pooled ORs and 95% CIs.
RESULTS: The search yielded 5351 unique records, of which two retrospective studies met the eligibility criteria. No randomised controlled trials were identified. The pooled population included 499 patients of which 19% (n = 95) received DSED and 81% (n = 404) were managed with standard resuscitation protocols. Confirmation of DSED was self-reported by paramedics. Neither study adjusted for confounding factors or baseline characteristics across the study groups. The definition of refractory VF and the protocol for DSED use differed across studies. Over half of cases were witnessed cardiac arrests (58.7%, n = 293) and bystander CPR was initiated in 53.3% (n = 266) of cases. In the meta-analysis, DSED had no effect on survival to hospital discharge (OR 0.69, 95% CI: 0.30, 1.60), event survival (OR 0.98, CI: 0.59, 1.62) or ROSC (OR 0.86, 95% CI: 0.49-1.48).
CONCLUSION: The effectiveness of DSED remains unclear. Further well-designed prospective studies are needed to determine whether DSED has a role in the treatment of refractory VF.
参考来源
- Delorenzo A, Nehme Z, Yates J, et al. Double sequential external defibrillation for refractory ventricular fibrillation out-of-hospital cardiac arrest: A systematic review and meta-analysis. Resuscitation. 2018. PMID: 30612966. doi:10.1016/j.resuscitation.2018.10.025
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。